Results
9
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
9 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MASTEK | ₹2,781.90 | 5.5% | 37.7% | ₹83.1b | ₹3,102.00 | PE28.5x | E18.4% | 0.7% | Software | ||
DBCORP | ₹364.55 | 3.9% | 65.5% | ₹63.5b | ₹437.50 | PE14x | E9.7% | 4.7% | Media | ||
513228 | ₹179.80 | 4.3% | 119.1% | ₹24.0b | ₹186.00 | PE24.7x | E26.6% | 0% | Materials | ||
UDS | ₹319.60 | 3.3% | n/a | ₹21.1b | ₹432.00 | PE31.5x | E34.4% | n/a | Commercial Services | ||
WONDERLA | ₹930.90 | 4.2% | 48.3% | ₹51.4b | ₹1,210.33 | PE33.3x | E16.7% | 0.3% | Consumer Services | ||
SHALBY | ₹279.95 | -1.3% | 42.9% | ₹29.8b | ₹350.00 | PE37.7x | E24.9% | 0.4% | Healthcare | ||
LTFOODS | ₹287.80 | 0.9% | 74.2% | ₹100.7b | ₹230.00 | PE16.4x | E10.4% | 0.5% | Food, Beverage & Tobacco | ||
MARKSANS | ₹200.32 | 8.1% | 72.6% | ₹91.1b | ₹240.00 | PE28.9x | E20.7% | 0.3% | Pharmaceuticals & Biotech | ||
GHCL | ₹542.30 | 3.1% | 4.0% | ₹51.2b | ₹543.00 | PE6.5x | E-3.5% | 2.2% | Materials |